Skip to main content
letter
. 2020 Jan 15;201(2):250–253. doi: 10.1164/rccm.201907-1343LE

Figure 1.

Figure 1.

Relationship between biomarker levels and progression-free survival in patients with (A) connective tissue disease–associated interstitial lung disease (ILD), (B) chronic hypersensitivity pneumonitis, or (C) unclassifiable ILD.